Kevin P. Siu
Watch for these three developments in AI law in 2026:…
Read More
ai biologics biosimilars class actions competition copyright evidence fair dealing infringement insufficiency legislation methods of medical treatment overbreadth patentable subject matter patents pharmaceuticals privacy procedure regulatory TPMs trademarks